Pheochromocytoma in an 8‐year‐old patient with multiple endocrine neoplasia type 2A: Implications for screening | Zendy

Rowland Kathryn J. | Zendy; Chernock Rebecca D. | Zendy; Moley Jeffrey F. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Pheochromocytoma in an 8‐year‐old patient with multiple endocrine neoplasia type 2A: Implications for screening

Author(s) -

Rowland Kathryn J.,

Chernock Rebecca D.,

Moley Jeffrey F.

Publication year - 2013

Publication title -

journal of surgical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.201

H-Index - 111

eISSN - 1096-9098

pISSN - 0022-4790

DOI - 10.1002/jso.23378

Subject(s) - medicine , pheochromocytoma , multiple endocrine neoplasia , multiple endocrine neoplasia type 2 , endocrine system , general surgery , oncology , hormone , mutation , genetics , germline mutation , gene , biology

Childhood pheochromocytoma in the setting of multiple endocrine neoplasia type 2 (MEN2) remains rare and has not been reported under the age of 12. We present an 8‐year‐old female with known MEN 2A, C634Y RET mutation, diagnosed with a 6 cm pheochromocytoma requiring laparoscopic adrenalectomy. Given this patient's age at diagnosis, screening guidelines should recommend annual screening beginning at age 8 for patients with MEN 2B or MEN 2A codons 630 or 634 RET mutations. J. Surg. Oncol. 2013 108:203–206 . © 2013 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research